| LEXXW Stock | | | USD 0.80 0.05 6.67% |
Lexaria Bioscience financial indicator trend analysis is infinitely more than just investigating Lexaria Bioscience Corp recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Lexaria Bioscience Corp is a good investment. Please check the relationship between Lexaria Bioscience Ebit Per Revenue and its Capex To Revenue accounts. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lexaria Bioscience Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in interest.
Ebit Per Revenue vs Capex To Revenue
Ebit Per Revenue vs Capex To Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Lexaria Bioscience Corp Ebit Per Revenue account and
Capex To Revenue. At this time, the significance of the direction appears to have pay attention.
The correlation between Lexaria Bioscience's Ebit Per Revenue and Capex To Revenue is -0.76. Overlapping area represents the amount of variation of Ebit Per Revenue that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of Lexaria Bioscience Corp, assuming nothing else is changed. The correlation between historical values of Lexaria Bioscience's Ebit Per Revenue and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebit Per Revenue of Lexaria Bioscience Corp are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Ebit Per Revenue i.e., Lexaria Bioscience's Ebit Per Revenue and Capex To Revenue go up and down completely randomly.
Correlation Coefficient | -0.76 |
| Relationship Direction | Negative |
| Relationship Strength | Weak |
Ebit Per Revenue
Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.
Most indicators from Lexaria Bioscience's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Lexaria Bioscience Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lexaria Bioscience Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in interest.
At this time, Lexaria Bioscience's
Issuance Of Capital Stock is fairly stable compared to the past year.
Enterprise Value Over EBITDA is likely to climb to 395.77 in 2024, whereas
Selling General Administrative is likely to drop slightly above 2.5
M in 2024.
Lexaria Bioscience fundamental ratios Correlations
Click cells to compare fundamentals
Lexaria Bioscience Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Lexaria Bioscience fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Lexaria Stock Analysis
When running Lexaria Bioscience's price analysis, check to
measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to
predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.